Glucagon-like peptide-1 receptor (GLP-1) agonists, particularly semaglutide, could be effective in reducing alcohol-related ...

Discover a trial in which patients received either IL-2 or a placebo for 5 days, followed by weekly doses for 4 weeks.

CAR T-cell therapy shows promise for solid tumors like glioblastoma. New engineering strategies and clinical trial results ...

NOVEL molecular regulators of rheumatoid arthritis (RA) inflammation were presented as part of a plenary abstract session at ...

Revisto has raised $4m in seed funding to simplify the pharmaceutical industry's marketing compliance processes using AI.

Testing for low placental growth factor during routine gestational diabetes screening could identify pregnant individuals at ...

A new report reveals high rates of preventable pregnancy-related cardiovascular deaths, underscoring racial disparities and ...

A recent study explores how MYCN-driven neuroblastoma hijacks the m6A modification process to prevent proper cell ...

No significant difference found between hydrocortisone replacement and prednisone tapering for glucocorticoid discontinuation ...

Average rating / 5. Vote count: No votes so far! Be the first to rate this content.

As the year barrels toward its finish, pharmaceutical marketers and medical affairs teams find themselves faced with familiar decision: how to allocate their remaining budget for maximum impact. The ...

Companies the world over are searching for the best ways to implement AI into their systems, and according to a new report from S&P Global, budgets will continue to be driven into this area. The ...